Description

N1-[(6S,10S)-6-Ethyl-2-[[[(4-fluorophenyl)methyl]amino]carbonyl]-6,7,9,10-tetrahydro-3-hydroxy-4-oxo-4H-pyrimido[1,2-d][1,4]oxazepin-10-yl]-N1,N2,N2-trimethylethanediamide is a high-purity, complex heterocyclic compound designed for advanced research and development. This molecule is of significant interest as a key pharmaceutical intermediate or active pharmaceutical ingredient (API) precursor, particularly in the development of novel therapeutic agents. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in cutting-edge drug discovery programs.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel drug candidates, particularly in oncology and central nervous system (CNS) therapeutic areas.
• Biochemical Research: Used as a reference standard or probe compound in pharmacological studies to investigate specific biological pathways and enzyme interactions.
• Preclinical Development: Employed in the formulation and testing stages of new chemical entities (NCEs) prior to clinical trials.
• Contract Research & Manufacturing (CRAM): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional laboratories for medicinal chemistry and organic synthesis projects.

Basic Information

Product Name	N1-[(6S,10S)-6-Ethyl-2-[[[(4-fluorophenyl)methyl]amino]carbonyl]-6,7,9,10-tetrahydro-3-hydroxy-4-oxo-4H-pyrimido[1,2-d][1,4]oxazepin-10-yl]-N1,N2,N2-trimethylethanediamide
CAS No.	1220510-45-1
Molecular Formula	C24H28FN5O6
Molecular Weight	501.51 g/mol
Synonyms	N1-[(6S,10S)-6-Ethyl-2-[[[(4-fluorophenyl)methyl]carbamoyl]-6,7,9,10-tetrahydro-3-hydroxy-4-oxo-4H-pyrimido[1,2-d][1,4]oxazepin-10-yl]-N1,N2,N2-trimethylethanediamide; (6S,10S)-10-[2-(Dimethylamino)-2-oxoacetamido]-6-ethyl-2-[[(4-fluorobenzyl)carbamoyl]-3-hydroxy-6,7,9,10-tetrahydro-4H-pyrimido[1,2-d][1,4]oxazepin-4-one; UNII-7J6K5Q8V6I; 7J6K5Q8V6I; Ethanediaamide, N1-[(6S,10S)-6-ethyl-2-[[[(4-fluorophenyl)methyl]amino]carbonyl]-6,7,9,10-tetrahydro-3-hydroxy-4-oxo-4H-pyrimido[1,2-d][1,4]oxazepin-10-yl]-N1,N2,N2-trimethyl-
EINECS	Contact for details

Quality Control

Our N1-[(6S,10S)-6-Ethyl-2-[[[(4-fluorophenyl)methyl]amino]carbonyl]-6,7,9,10-tetrahydro-3-hydroxy-4-oxo-4H-pyrimido[1,2-d][1,4]oxazepin-10-yl]-N1,N2,N2-trimethylethanediamide is manufactured under a strict quality management system. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. A detailed Certificate of Analysis (COA) is provided with each shipment, confirming compliance with client specifications and relevant industry guidelines for advanced pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept under anhydrous conditions. For long-term storage, consider storing under an inert atmosphere such as nitrogen or argon.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.